To enable advanced cancer patients to cope with difficulties at the end of life, JGH researchers hope to develop better psychological support through an intervention that helps individuals find meaning in their radically altered lives.
A pioneering research program is connecting artificial intelligence with the new field of radiomics to heighten the effectiveness of cancer treatment by gleaning as much information as possible from radiological imaging technology.
The potential of manipulating a particular protein is being explored as a possible alternative to blood thinners, which are the standard of care for venous thromboembolism, but whose association with severe bleeding makes blood thinners an imperfect remedy.
The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.
Dr. Pierre Pluye, a Senior Investigator in the Centre for Clinical Epidemiology and Community Studies at the Lady Davis Institute, has been named 2017 Family Medicine Researcher of the Year by the College of Family Physicians of Canada.
In the most recent round of funding by the Canadian Institutes of Health Research, Dr. Stéphane Richard received a CIHR Foundation Grant worth $3.5 million over seven years.
Dr. Roderick McInnes, Director of the Lady Davis Institute at the JGH, is being honoured with the 2017 Distinguished Scientist Award by the Canadian Society for Clinical Investigation.
In the ongoing fight against dementia, a research team in the Lady Davis Institute, is looking at electro-magnetic stimulation as a method of targeting the illness through the brain’s electrical impulses.